Ms. Lynn Bennett Mcmorrow, NP Nurse Practitioner - Family Medicare: May Accept Medicare Assignments Practice Location: 382 Main St, Enosburg Falls, VT 05450 Phone: 802-933-5831 |
Catherine Hall, NP Nurse Practitioner - Adult Health Medicare: Accepting Medicare Assignments Practice Location: 84 Water Tower Rd Ste 1, Enosburg Falls, VT 05450 Phone: 802-933-6664 |
Karen Towle, NP Nurse Practitioner - Family Medicare: May Accept Medicare Assignments Practice Location: 382 Main St, Enosburg Falls, VT 05450 Phone: 802-933-5831 Fax: 802-933-5836 |
Richard William Gallagher, AGNP Nurse Practitioner - Adult Health Medicare: May Accept Medicare Assignments Practice Location: Enosburg Health Center, 382 Main Street, Enosburg Falls, VT 05450 Phone: 802-933-5831 Fax: 802-933-5836 |
Michelle Robert, FNP-C Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 382 Main St, Enosburg Falls, VT 05450 Phone: 802-993-5831 |
Ms. Katherine Michelle Kasowitz, APRN Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 382 Main St, Enosburg Falls, VT 05450 Phone: 802-933-5831 Fax: 802-933-2362 |
Samantha O'sullivan Cooney, Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 84 Water Tower Rd # 1, Enosburg Falls, VT 05450 Phone: 802-933-6664 Fax: 802-933-8333 |
News Archive
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that its ToleroMune(R) ragweed allergy T-cell vaccine achieved positive results in a recently completed phase II clinical trial. Ragweed allergy is particularly common in America, where it affects approximately 25% of the population. Circassia's latest clinical results follow two earlier successful phase II studies with the company's T-cell vaccine against cat allergy.
New guidelines developed by the American Academy of Neurology and the American Epilepsy Society show it's relatively safe for women with epilepsy to become pregnant, but caution must be taken, including avoiding one particular epilepsy drug that can cause birth defects.
Advanced Medical Isotope Corporation, a late stage development company engaged primarily in the development of brachytherapy devices and medical isotopes for diagnostic and therapeutic applications, today announced that it has filed a de novo submission with the Food and Drug Administration for marketing clearance for its patented Y-90 RadioGel(TM) device pursuant to Section 513(f)(2) of the U.S. Food, Drug and Cosmetic Act.
Patients with ulcerative colitis take more time off work than the general population, even after undergoing colectomy, shows a large Swedish study.
› Verified 5 days ago